Drreddys Laboratories | RDY - Assets


Drreddys Laboratories reported INR6.26B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
ANI Pharmaceuticals USD 1.41B 65.15M Sep/2025
Aurora Cannabis CAD 756.86M 80.98M Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Cipla INR 401.64B 27.77B Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Lonza CHF 19.73B 1.85B Dec/2024
Novartis USD 107.29B 2.89B Sep/2025
Pacira USD 1.3B 239.68M Sep/2025
Prestige Brands USD 3.44B 10.66M Sep/2025
Richter Gedeon HUF 1.64T 38.58B Sep/2025
Sun Pharmaceuticals INR 1.04T 116.06B Sep/2025
Supernus Pharmaceuticals USD 1.42B 37.35M Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025